Activist 13D/13G Filings - Correvio Pharma Corp. (CRME)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2020-05-26
5:30 pm
Purchase
13GCORREVIO PHARMA CORP COM
CORV
Klein Roger M.8,000,373
12.07%
4,326,681increase
(+117.77%)
View
2020-04-16
5:29 pm
Purchase
13GCORREVIO PHARMA CORP COM
CORV
Klein Roger M.3,673,692
5.55%
3,673,692increase
(New Position)
View
2020-02-24
08:34 am
Sale
13GCORREVIO PHARMA CORP COM
CORV
Clough Capital Partners L P0
0%
-2,111,224decrease
(Position Closed)
View
2020-02-14
09:49 am
Sale
13GCORREVIO PHARMA CORP COM
CORV
PUTNAM INVESTMENTS LLC0
0%
-3,092,133decrease
(Position Closed)
View
2020-02-13
9:39 pm
Purchase
13GCORREVIO PHARMA CORP COM
CORV
Tamarack Advisers LP2,500,000
4.9%
375,000increase
(+17.65%)
View
2020-01-07
08:36 am
Sale
13GCORREVIO PHARMA CORP COM
CORV
WESTFIELD CAPITAL MANAGEMENT CO LP0
0%
-4,894,685decrease
(Position Closed)
View
2019-09-04
1:59 pm
Purchase
13GCORREVIO PHARMA CORP COM
CORV
WESTFIELD CAPITAL MANAGEMENT CO LP4,894,685
9.69%
106,653increase
(+2.23%)
View